Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers 2022-04-04 23:35
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province 2022-04-04 17:10
Clarivate Healthcare Business Insights Announces 2021 Revenue Cycle Awards Recipients 2022-04-04 16:00
Telix, GMS and Monash Awarded $23M Federal Government Funding as part of $71M Australian Precision Medicine Enterprise (APME) Project 2022-04-04 09:13
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
Ascletis Announces Submission of Marketing Authorization Application for Ritonavir in Hong Kong 2022-04-03 18:20
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers 2022-04-01 16:55
NCCN Annual Conference Focuses on Cancer Patient Journey; with Cutting-Edge Research and Latest Evidence-Based Care Recommendations 2022-03-31 20:56
Brii Bio Presents New Data on BRII-835 (VIR-2218) in Chinese Patients with Chronic Hepatitis B at APASL 2022 2022-03-31 18:05
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2022-03-31 17:00
Ascletis Announces Completion of Patient Enrollment in Phase II Clinical Trial of ASC42, an In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication 2022-03-30 18:26
GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row 2022-03-30 17:30
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
Terumo and Glooko Announce Collaboration on New Solution for Diabetes Data Sharing 2022-03-30 15:00
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights 2022-03-30 10:36
First Year of Commercialization, Alphamab Oncology Reports Full Year 2021 Financial Results and Business Highlights 2022-03-30 10:35
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market 2022-03-30 10:22
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines 2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
1 50 51 52 53 54 229